Sen. Edward Markey, D-Mass., sent a letter to the head of the FDA Dec. 14 urging the agency to investigate Reuters‘ findings to determine whether the pharmaceutical giant misled regulators and whether its baby powder products threaten public health and safety.
In response to the Reuters report, J&J said “any suggestion that Johnson & Johnson knew or hid information about the safety of talc is false.”
J&J rebutted Reuters‘ report in a written critique of the article and a video from company CEO Alex Gorsky.
In the written critique, J&J said Reuters left out information it supplied to the news outlet that showed its baby powder is safe and does not cause cancer; that the baby powder has repeatedly been found to be asbestos-free; and that J&J has cooperated with the FDA and other regulators to give information requested over decades.
More articles on supply chain:
Colorado hospitals closing blood donation centers, Vitalant assumes role
Walmart extends contract with Express Scripts
Shingles vaccine shortage worsens
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
